Renal Safety Evaluation After Dotarem®-Enhanced MRI
NCT00650845
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Insufficiency
Interventions
DRUG:
Dotarem®-enhanced MRI
OTHER:
non-enhanced MRI
Sponsor
Guerbet